Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
41 studies found for:    RGD
Show Display Options
Rank Status Study
1 Recruiting 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Drug: 68Ga-NOTA-BBN-RGD
2 Recruiting Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: 68Ga-NOTA-BBN-RGD
3 Completed Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Tenckhoff Catheter placement;   Drug: Ad5-delta24RGD
4 Recruiting Dual Integrin αvβ3 and SSTR2 Targeting PET Imaging in Lung Cancer Patients
Condition: Lung Cancer
Intervention: Drug: 68Ga-NOTA-3PTATE-RGD
5 Recruiting 68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis
Condition: Pathological Angiogenesis
Interventions: Radiation: 68Ga-NODAGA-RGD PET/CT;   Radiation: 18F-FDG PET/CT;   Radiation: 18F-FET PET/CT
6 Recruiting Study of the Angiogenesis by PET/CT in Patients With Diffuse Large B Cells Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Intervention: Device: RGD K5 PET scan
7 Recruiting Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque
Conditions: Inflammation;   Atheromatous Plaques;   Carotid Artery Diseases
Intervention: Radiation: 68Ga-NODAGA-RGD PET/CT
8 Completed Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
Conditions: Metastatic Breast Cancer;   Metastatic Colon/Rectum Cancer;   Non-squamous Non-small Cell Lung Cancer
Intervention: Drug: [F-18]RGD-K5
9 Completed Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Conditions: Sarcoma;   Melanoma;   Lung Cancer;   Breast Cancer;   High Grade Gliomas
Intervention: Drug: F-18 RGD-K5
10 Completed Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Recurring Glioblastoma
Intervention: Biological: delta-24-RGD adenovirus
11 Unknown  RGD-PET-CT in Cancer Angiogenesis
Condition: Carcinoma, Renal Cell
Intervention: Drug: 18F-RGD-PET-CT and perfusion CT scans on 3 occasions
12 Terminated
Has Results
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
Condition: Carotid Stenosis
Intervention: Drug: [F-18]RDG-K5
13 Unknown  RGD-K5 in Head and Neck Cancer Patients
Condition: Head and Neck Neoplasms
14 Recruiting PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
Conditions: Advanced Head and Neck Carcinoma;   Advanced Non-small Cell Lung Carcinoma
Intervention: Drug: radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)
15 Terminated TRACER RGD-K5 Carotid Plaque Imaging Study
Conditions: Carotid Artery Disease;   Carotid Stenosis
Intervention: Drug: [F-18] RDG-K5
16 Completed DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Conditions: Brain Cancer;   Central Nervous System Diseases
Interventions: Drug: DNX-2401;   Procedure: Tumor Removal
17 Recruiting Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
Conditions: Non-seminomatous Germ Cell Tumors;   Metastasis
Interventions: Other: K5-RGD PET;   Other: FDG
18 Completed A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
Condition: Ovarian Cancer
Interventions: Genetic: Ad5.SSTR/TK.RGD;   Drug: Ganciclovir (GCV)
19 Completed 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT
Conditions: Lung Cancer;   Lung Tuberculosis
Intervention: Radiation: 68Ga-labeled peptides of dimer RGD (Alfatide II) and 18F-FDG
20 Active, not recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.